GlycoMimetics Inc (NASDAQ: GLYC) kicked off on Tuesday, up 191.32% from the previous trading day, before settling in for the closing price of $0.17. Over the past 52 weeks, GLYC has traded in a range of $0.14-$3.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -53.76%. While this was happening, its average annual earnings per share was recorded 12.93%. With a float of $59.08 million, this company’s outstanding shares have now reached $64.39 million.
Let’s determine the extent of company efficiency that accounts for 35 employees. In terms of profitability, gross margin is -3102.77%, operating margin of -98445597.2%, and the pretax margin is -391140.73%.
GlycoMimetics Inc (GLYC) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of GlycoMimetics Inc is 8.38%, while institutional ownership is 35.62%. The most recent insider transaction that took place on Aug 08 ’24, was worth 50,009. In this transaction 10% Owner of this company sold 260,873 shares at a rate of $0.19, taking the stock ownership to the 6,317,565 shares. Before that another transaction happened on Aug 07 ’24, when Company’s 10% Owner sold 61,488 for $0.18, making the entire transaction worth $11,197. This insider now owns 6,578,438 shares in total.
GlycoMimetics Inc (GLYC) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.14 earnings per share (EPS), higher than consensus estimate (set at -0.14) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.07 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 12.93% per share during the next fiscal year.
GlycoMimetics Inc (NASDAQ: GLYC) Trading Performance Indicators
Take a look at GlycoMimetics Inc’s (GLYC) current performance indicators. Last quarter, stock had a quick ratio of 5.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3159.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.61, a number that is poised to hit -0.11 in the next quarter and is forecasted to reach -0.09 in one year’s time.
Technical Analysis of GlycoMimetics Inc (GLYC)
Looking closely at GlycoMimetics Inc (NASDAQ: GLYC), its last 5-days average volume was 226.02 million, which is a jump from its year-to-date volume of 7.23 million. As of the previous 9 days, the stock’s Stochastic %D was 48.59%. Additionally, its Average True Range was 0.05.
During the past 100 days, GlycoMimetics Inc’s (GLYC) raw stochastic average was set at 71.39%, which indicates a significant increase from 71.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 430.43% in the past 14 days, which was higher than the 192.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.1719, while its 200-day Moving Average is $1.1909. However, in the short run, GlycoMimetics Inc’s stock first resistance to watch stands at $0.6396. Second resistance stands at $0.7893. The third major resistance level sits at $0.9485. If the price goes on to break the first support level at $0.3307, it is likely to go to the next support level at $0.1715. Now, if the price goes above the second support level, the third support stands at $0.0218.
GlycoMimetics Inc (NASDAQ: GLYC) Key Stats
The company with the Market Capitalisation of 31.60 million has total of 64,484K Shares Outstanding. Its annual sales at the moment are 10 K in contrast with the sum of -36,900 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -10,740 K.
